JP2013241464A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013241464A5 JP2013241464A5 JP2013169146A JP2013169146A JP2013241464A5 JP 2013241464 A5 JP2013241464 A5 JP 2013241464A5 JP 2013169146 A JP2013169146 A JP 2013169146A JP 2013169146 A JP2013169146 A JP 2013169146A JP 2013241464 A5 JP2013241464 A5 JP 2013241464A5
- Authority
- JP
- Japan
- Prior art keywords
- conjunctivitis
- levofloxacin
- eye
- eye drop
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003889 eye drop Substances 0.000 claims 20
- 206010010741 Conjunctivitis Diseases 0.000 claims 17
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 claims 15
- 229960003376 levofloxacin Drugs 0.000 claims 15
- 206010022000 influenza Diseases 0.000 claims 8
- 241000894006 Bacteria Species 0.000 claims 7
- 241000589519 Comamonas Species 0.000 claims 6
- 241000194032 Enterococcus faecalis Species 0.000 claims 6
- 241000191967 Staphylococcus aureus Species 0.000 claims 6
- 241000191963 Staphylococcus epidermidis Species 0.000 claims 6
- 229940012356 eye drops Drugs 0.000 claims 6
- 241000588769 Proteus <enterobacteria> Species 0.000 claims 5
- 244000052616 bacterial pathogen Species 0.000 claims 5
- 244000005700 microbiome Species 0.000 claims 5
- 241000186216 Corynebacterium Species 0.000 claims 4
- 241000588914 Enterobacter Species 0.000 claims 4
- 241000233866 Fungi Species 0.000 claims 4
- 241000607720 Serratia Species 0.000 claims 4
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 4
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 4
- 241001600125 Delftia acidovorans Species 0.000 claims 3
- 241000295644 Staphylococcaceae Species 0.000 claims 3
- 241000191940 Staphylococcus Species 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 3
- 239000006196 drop Substances 0.000 claims 3
- 229940032049 enterococcus faecalis Drugs 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000012453 solvate Substances 0.000 claims 3
- 208000002874 Acne Vulgaris Diseases 0.000 claims 2
- 241000588915 Klebsiella aerogenes Species 0.000 claims 2
- 241000607715 Serratia marcescens Species 0.000 claims 2
- 206010000496 acne Diseases 0.000 claims 2
- 201000007032 bacterial conjunctivitis Diseases 0.000 claims 2
- 229940092559 enterobacter aerogenes Drugs 0.000 claims 2
- 241000194033 Enterococcus Species 0.000 claims 1
- 241000606790 Haemophilus Species 0.000 claims 1
- 241000606768 Haemophilus influenzae Species 0.000 claims 1
- 241000588748 Klebsiella Species 0.000 claims 1
- 241000588770 Proteus mirabilis Species 0.000 claims 1
- 229940047650 haemophilus influenzae Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013169146A JP5674882B2 (ja) | 2010-02-25 | 2013-08-16 | レボフロキサシンもしくはその塩またはそれらの溶媒和物を含有する結膜炎治療用点眼剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010040281 | 2010-02-25 | ||
| JP2010040281 | 2010-02-25 | ||
| JP2013169146A JP5674882B2 (ja) | 2010-02-25 | 2013-08-16 | レボフロキサシンもしくはその塩またはそれらの溶媒和物を含有する結膜炎治療用点眼剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012054761A Division JP2012162532A (ja) | 2010-02-25 | 2012-03-12 | レボフロキサシンもしくはその塩またはそれらの溶媒和物を含有する結膜炎治療用点眼剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013241464A JP2013241464A (ja) | 2013-12-05 |
| JP2013241464A5 true JP2013241464A5 (https=) | 2014-01-30 |
| JP5674882B2 JP5674882B2 (ja) | 2015-02-25 |
Family
ID=44506417
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010280325A Active JP5600056B2 (ja) | 2010-02-25 | 2010-12-16 | レボフロキサシンもしくはその塩またはそれらの溶媒和物を含有する眼感染症治療用点眼剤 |
| JP2012054761A Pending JP2012162532A (ja) | 2010-02-25 | 2012-03-12 | レボフロキサシンもしくはその塩またはそれらの溶媒和物を含有する結膜炎治療用点眼剤 |
| JP2013169146A Active JP5674882B2 (ja) | 2010-02-25 | 2013-08-16 | レボフロキサシンもしくはその塩またはそれらの溶媒和物を含有する結膜炎治療用点眼剤 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010280325A Active JP5600056B2 (ja) | 2010-02-25 | 2010-12-16 | レボフロキサシンもしくはその塩またはそれらの溶媒和物を含有する眼感染症治療用点眼剤 |
| JP2012054761A Pending JP2012162532A (ja) | 2010-02-25 | 2012-03-12 | レボフロキサシンもしくはその塩またはそれらの溶媒和物を含有する結膜炎治療用点眼剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20120316158A1 (https=) |
| EP (1) | EP2540299B1 (https=) |
| JP (3) | JP5600056B2 (https=) |
| KR (2) | KR20130043611A (https=) |
| CN (1) | CN102770141A (https=) |
| BR (1) | BR112012021247A2 (https=) |
| CA (1) | CA2791190C (https=) |
| EA (1) | EA201290827A1 (https=) |
| ES (1) | ES2568647T3 (https=) |
| MX (1) | MX349603B (https=) |
| MY (1) | MY183483A (https=) |
| NZ (1) | NZ602126A (https=) |
| PH (2) | PH12016501747B1 (https=) |
| SG (1) | SG183427A1 (https=) |
| TW (1) | TWI488627B (https=) |
| WO (1) | WO2011104981A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12016501747B1 (en) * | 2010-02-25 | 2022-06-22 | Daiichi Sankyo Co Ltd | Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, method for treating ocular infection, levofloxacin or salt thereof or solvate of the same, and the use thereof |
| CN103550144B (zh) * | 2013-10-25 | 2015-10-14 | 深圳朗欧医药集团有限公司 | 盐酸左氧氟沙星组合物注射液及其制备方法 |
| JP6363833B2 (ja) * | 2013-11-22 | 2018-07-25 | ナノシータ株式会社 | 薄膜状高分子構造体 |
| CN104606198A (zh) * | 2015-01-09 | 2015-05-13 | 周元铎 | 盐酸左氧氟沙星在制备防治家蚕细菌性败血病药中的应用 |
| IT201900005280A1 (it) * | 2019-04-05 | 2020-10-05 | Ntc S R L | Composizione otologica |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3038722B2 (ja) | 1989-06-23 | 2000-05-08 | 日本電気株式会社 | 接合型電界効果トランジスタ |
| JP3192290B2 (ja) | 1993-08-04 | 2001-07-23 | カネボウ株式会社 | ポリエステル製耐熱ボトル |
| WO2003028664A2 (en) * | 2001-10-03 | 2003-04-10 | Teva Pharmaceutical Industries Ltd. | Preparation of levofloxacin and forms thereof |
| EP1458391B1 (en) * | 2001-11-30 | 2007-09-05 | LG Life Sciences Ltd. | A method of treating bacterial infections using gemifloxacin or a salt thereof and a beta-lactam antibiotic |
| US20050009836A1 (en) | 2003-06-26 | 2005-01-13 | Laskar Paul A. | Ophthalmic composition containing quinolones and method of use |
| WO2005000307A1 (en) * | 2003-06-26 | 2005-01-06 | Santen Pharmaceutical Co., Ltd. | Ophthalmic composition containing quinolones and method of use |
| ES2671342T3 (es) * | 2006-02-10 | 2018-06-06 | Pari Pharma Gmbh | Antibióticos nebulizados para terapia de inhalación |
| WO2008005276A2 (en) * | 2006-06-30 | 2008-01-10 | Directcontact Llc | Growth factor delivery system containing antimicrobial agents |
| EP2143422A1 (en) * | 2008-07-11 | 2010-01-13 | S.I.F.I - Società Industria Farmaceutica Italiana - S.P.A. | Ophthalmic compositions containing gemifloxacin for the treatment of ocular infections |
| PH12016501747B1 (en) * | 2010-02-25 | 2022-06-22 | Daiichi Sankyo Co Ltd | Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, method for treating ocular infection, levofloxacin or salt thereof or solvate of the same, and the use thereof |
-
2010
- 2010-12-16 PH PH1/2016/501747A patent/PH12016501747B1/en unknown
- 2010-12-16 SG SG2012061842A patent/SG183427A1/en unknown
- 2010-12-16 MX MX2012009844A patent/MX349603B/es active IP Right Grant
- 2010-12-16 KR KR1020127024069A patent/KR20130043611A/ko not_active Ceased
- 2010-12-16 US US13/580,931 patent/US20120316158A1/en not_active Abandoned
- 2010-12-16 WO PCT/JP2010/072685 patent/WO2011104981A1/ja not_active Ceased
- 2010-12-16 NZ NZ602126A patent/NZ602126A/xx not_active IP Right Cessation
- 2010-12-16 BR BR112012021247-8A patent/BR112012021247A2/pt not_active Application Discontinuation
- 2010-12-16 PH PH1/2012/501674A patent/PH12012501674A1/en unknown
- 2010-12-16 MY MYPI2012003769A patent/MY183483A/en unknown
- 2010-12-16 EA EA201290827A patent/EA201290827A1/ru unknown
- 2010-12-16 ES ES10846644.2T patent/ES2568647T3/es active Active
- 2010-12-16 EP EP10846644.2A patent/EP2540299B1/en not_active Not-in-force
- 2010-12-16 CN CN2010800646540A patent/CN102770141A/zh active Pending
- 2010-12-16 JP JP2010280325A patent/JP5600056B2/ja active Active
- 2010-12-16 KR KR1020177015979A patent/KR20170070265A/ko not_active Ceased
- 2010-12-16 CA CA2791190A patent/CA2791190C/en not_active Expired - Fee Related
- 2010-12-28 TW TW099146206A patent/TWI488627B/zh not_active IP Right Cessation
-
2012
- 2012-03-12 JP JP2012054761A patent/JP2012162532A/ja active Pending
-
2013
- 2013-08-16 JP JP2013169146A patent/JP5674882B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013241464A5 (https=) | ||
| Gebreyesus et al. | Nasal and hand carriage rate of methicillin resistant Staphylococcus aureus (MRSA) among health care workers in Mekelle Hospital, North Ethiopia | |
| PH12019500360A1 (en) | Antibiotic compounds | |
| WO2016049586A3 (en) | Non-beta lactam antibiotics | |
| PH12016502436A1 (en) | Anti-infective compounds | |
| Mirani et al. | Small colony variants have a major role in stability and persistence of Staphylococcus aureus biofilms | |
| MX2019003060A (es) | Compuestos inhibidores de beta-lactamasa. | |
| BR112017010132A2 (pt) | terapia combinada para tratamento de infecções bacterianas resistentes | |
| EA201691766A1 (ru) | Органические соединения, являющиеся монобактамами, для лечения бактериальных инфекций | |
| MY209256A (en) | Compounds affecting pigment production and use thereof for treatment of bacterial diseases | |
| JP2017519730A5 (https=) | ||
| PH12017500290B1 (en) | Heterobicyclic compounds and their use for the treatment of tuberculosis | |
| PH12019502509A1 (en) | Compounds and methods for treating bacterial infections | |
| WO2017218922A8 (en) | Compositions and methods for the treatment of bacterial infections | |
| CO2021015337A2 (es) | Métodos y composiciones que comprenden variantes de la proteína a de estafilococos (spa) | |
| WO2015024021A3 (en) | Antibacterial compounds | |
| WO2017137954A3 (en) | Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease | |
| WO2013041663A3 (de) | Modifizierte apidaecinderivate als antibiotische peptide | |
| WO2015114452A3 (en) | Antibacterial combinations comprising polymyxin | |
| MX380076B (es) | Inhibidores de beta-lactamasa. | |
| EA201590876A1 (ru) | Спироизоксазолиновые соединения, обладающие активностью, усиливающей активность антибиотика | |
| MX373098B (es) | Derivados de manosa para tratar infecciones bacterianas. | |
| IN2014DE02523A (https=) | ||
| BR112017008101A2 (pt) | composto, composição farmacêutica, métodos para inibir o dnae bacteriano e para tratar uma infecção, e, uso de um composto. | |
| PL410757A1 (pl) | Nowy szczep Lactobacillus plantarum PL3, jego metabolit oraz zastosowanie szczepu Lactobacillus plantarum PL3 i jego metabolitu |